Business
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine – FDA.gov
The FDA issued an EUA for the Janssen COVID-19 Vaccine, allowing the vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
For Immediate Release:
February 27, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
The authorization of this vaccine expands the availability of vaccines, the best medical prevention…
